According to an article on G2 Intelligence, “the Centers for Medicare and Medicaid Services (CMS) said it would solicit, in the proposed Medicare physician fee schedule rule for 2013, recommendations on the placement and pricing of new CPT molecular diagnostic codes introduced this year by the American Medical Association (AMA) but not yet recognized by Medicare.”

Click here to read the entire article.

Source: G2 Intelligence